Influenza virus vaccines from seqirus USA INC.:1334893 [24-007622]
Ended Awarded Last action
- Contract number
- 75N90024F00001
- Awardee
-
Seqirus USA Inc. UEI N6U7P2B9VHS5
- Awarding agency
-
NIH Clinical Center
National Institutes of Health, Department of Health and Human Services
- Obligated
- $307,666
Award facts
- Contract value 100% obligated
- $307,666.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- King of Prussia, PA 19406, USA
Award details come from SAM.gov/FPDS.
About this award
This is a federal contract award to Seqirus USA Inc., a foreign-owned, for-profit biotechnology company, for the delivery of influenza virus vaccines. The contract has a ceiling value of $307,666.00 and an ultimate completion date of April 26, 2025. It was awarded on April 27, 2020 by the National Institutes of Health (NIH) Clinical Center, a civilian federal agency. The contract is a Blanket Purchase Agreement (BPA) call with a firm-fixed-price pricing type.
Seqirus USA Inc. is a global leader in the development, manufacturing, and delivery of influenza vaccines to various federal government agencies. The company has established itself as a critical supplier of vaccines to federal healthcare systems, supporting immunization efforts across multiple agencies. This contract award is not set aside and demonstrates Seqirus's competitive capabilities in the federal marketplace. Seqirus USA Inc. also holds several significant Indefinite Delivery Contracts (IDCs) with agencies such as the Department of Veterans Affairs, Defense Logistics Agency, and Centers for Disease Control and Prevention for the supply of adult and pediatric flu vaccines.
Quick answers
Who was awarded contract 75N90024F00001?
75N90024F00001 was awarded to Seqirus USA Inc. by NIH Clinical Center (National Institutes of Health) on April 27, 2020.
How much is contract 75N90024F00001 worth?
The government has obligated $307,666 on 75N90024F00001.
Is contract 75N90024F00001 an order under another contract?
Yes. 75N90024F00001 is a BPA call under V797D70074-75N90020A00004, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 75N90024F00001 competed?
The extent of competition for 75N90024F00001 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award